LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 117 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,601 | -44.5% | 28,475 | -33.7% | 0.00% | – |
Q2 2023 | $60,528 | -27.1% | 42,928 | -20.0% | 0.00% | – |
Q1 2022 | $83,000 | -50.0% | 53,656 | -20.8% | 0.00% | – |
Q4 2021 | $166,000 | +1.2% | 67,780 | +4.0% | 0.00% | – |
Q3 2021 | $164,000 | -65.6% | 65,203 | -61.0% | 0.00% | -100.0% |
Q2 2021 | $477,000 | +243.2% | 167,396 | -0.6% | 0.00% | – |
Q1 2020 | $139,000 | -6.1% | 168,433 | +1.2% | 0.00% | – |
Q4 2019 | $148,000 | -9.2% | 166,508 | 0.0% | 0.00% | – |
Q3 2019 | $163,000 | – | 166,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $40,874,517 | 3.42% |
Defender Capital, LLC. | 5,093,535 | $5,959,436 | 2.41% |
Raffles Associates | 1,536,946 | $1,798,230 | 2.10% |
Prescott General Partners LLC | 1,851,851 | $2,166,666 | 0.18% |
DAFNA Capital Management LLC | 140,000 | $163,800 | 0.05% |
Fort Sheridan Advisors LLC | 83,931 | $98,199 | 0.03% |
Beirne Wealth Consulting Services, LLC | 45,000 | $52,650 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $914,666 | 0.02% |
ETF MANAGERS GROUP, LLC | 353,991 | $414,169 | 0.02% |
Straight Path Wealth Management | 16,200 | $18,954 | 0.02% |